Assistant Professor, Internal Medicine, Mayo Medical School
Cardiology
Dr. Gregory W. Barsness, MD
|
|
Give Review
Gregory W. Barsness is an expert in the field of Cardiology. He studied medicine at University of Minnesota Medical School. University of Minnesota Medical School has a rank of 40 in research and a 10 in primary care He received 1 awards: "Fellow (FACC)". Gregory Barsness is also a published doctor. He has 74 publication published. The most recent publication is: Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions. Gregory Barsness accepts Medicare payments and is listed with Medicare.gov.
Publications
- Long-Term Outcomes in Survivors of Early Ventricular Arrhythmias After Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary...
- Effect of a Shortened-Duration Eptifibatide Infusion (75 mg) as Adjunctive Therapy for Percutaneous Coronary Intervention on Inhospital Cardiovascular Outcomes and Ble...
- Heparin dose adjustment required to maintain goal-activated partial thromboplastin time during therapeutic hypothermia.
- Pneumatic compression for embolic protection during upper extremity endovascular intervention.
- EPC mobilization after erythropoietin treatment in Acute ST-elevation myocardial infarction: the REVEAL EPC substudy.
- Coronary endothelial dysfunction in patients with early Coronary artery disease is associated with the increase in intravascular lipid core plaque.
- Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
- Plaque characteristics and arterial remodeling in Coronary and peripheral arterial systems.
- Short-term effects of enhanced external counterpulsation on transthoracic Coronary flow velocity and reserve in patients with Coronary slow flow.
- Collateralization of an occluded left internal mammary artery Coronary bypass graft.
- Subclavian Artery endovascular intervention for vertebrobasilar ischemia: the use of dual arterial access and embolic protection.
- Transradial iliac Artery intervention with dual downstream embolic protection.
- Pexelizumab and infarct size in patients with Acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic...
- Coronary venoplasty-assisted implantation of cardiac resynchronization device in a patient with persistent left superior vena cava.
- Percutaneous subclavian Artery bypass for myocardial perfusion during endovascular intervention.
- Embolic protection devices in patients with renal Artery stenosis with chronic renal insufficiency: a clinical study.
- Preliminary study of the use of drug-eluting stents in atherosclerotic renal Artery stenoses 4 mm in diameter or smaller.
- Enhanced external counterpulsation in the treatment of chronic refractory Angina: a long-term follow-up outcome from the International Enhanced External Counterpulsati...
- Association between the paraoxonase-1 192Q>R allelic variant and Coronary endothelial dysfunction in patients with early Coronary artery disease.
- The interaction between Coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans.
- Emerging therapies for refractory Angina.
- Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing Coronary angiography.
- Lipoprotein-associated phospholipase A2 is an independent marker for Coronary endothelial dysfunction in humans.
- Integrated management of patients with diabetes mellitus and ischemic Heart disease: PCI, CABG, and medical therapy.
- Incidence, retrieval methods, and outcomes of stent loss during percutaneous Coronary intervention: a large single-center experience.
- Intravascular ultrasound-guided treatment for angiographically indeterminate left main Coronary artery disease: a long-term follow-up study.
- Current and future treatment strategies for refractory Angina.
- Successful treatment of symptomatic Coronary endothelial dysfunction with enhanced external counterpulsation.
- Enhanced external counterpulsation for ischemic Heart disease: what's behind the curtain?
- Enhanced external counterpulsation improves endothelial function in patients with symptomatic Coronary artery disease.
- Safety and efficacy of cutting balloon angioplasty: the Mayo Clinic experience.
- Incidence and prognostic importance of Acute renal failure after percutaneous coronary intervention.
- Endocrine Heart Disease.
- Diabetes and Coronary Intervention: Special Considerations for Antithrombotic Therapy.
- Improving Endothelial Function with ACE Inhibitors: An Important Therapeutic Target After Coronary Interventions.
- Enhanced External Counterpulsation in Unrevascularizable Patients.
- Frequency and efficacy of repeat enhanced external counterpulsation for stable Angina pectoris (from the International EECP Patient Registry).
- Primer: practical approach to the selection of patients for and application of EECP.
- Evolving treatment strategies for chronic refractory Angina.
- Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
- Effectiveness of enhanced external counterpulsation in patients with left main disease and Angina.
- The association between renal atherosclerotic plaque characteristics and renal function before and after renal Artery intervention.
- Intravenous erythropoietin in patients with ST-segment elevation Myocardial infarction: REVEAL: a randomized controlled trial.
- Sex differences in atheroma burden and endothelial function in patients with early Coronary atherosclerosis.
- Nonrevascularizable Coronary artery disease following Coronary artery bypass graft surgery: a population-based study in Olmsted County, Minnesota.
- The efficacy and safety of enhanced external counterpulsation in patients with peripheral arterial Disease.
- Transradial Access for Renal Artery Intervention is Feasible and Safe.
- Unstable Angina due to stent fracture.
- Myocardial perfusion in apical ballooning Syndrome correlate of myocardial injury.
- Effectiveness of repeat enhanced external counterpulsation for refractory Angina in patients failing to complete an initial course of therapy.
- Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Tr...
- Predictors of benefit in Angina patients one year after completing enhanced external counterpulsation: initial responders to treatment versus nonresponders.
- Enhanced External Counterpulsation for the relief of Angina in patients with diabetes: safety, efficacy and 1-year clinical outcomes.
- Comparison of survival after successful percutaneous Coronary intervention of patients with diabetes mellitus receiving insulin versus those receiving only diet and/or...
- Effectiveness and safety of abciximab after failed thrombolytic therapy.
- The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and Acute results.
- Relationship between diabetes mellitus and long-term survival after Coronary bypass and angioplasty.
- Prognostic value of congestive Heart failure history in patients undergoing percutaneous coronary interventions.
- Clopidogrel versus ticlopidine after intraCoronary stent placement.
- Local delivery of heparin post-PTCA: a multicenter randomized pilot study.
- Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts.
- Application of the New York State PTCA mortality model in patients undergoing stent implantation.
- Issues and challenges with antithrombotic therapy in diabetic patients with Acute coronary syndromes.
- Noninvasive revascularization by enhanced external counterpulsation: a case study and literature review.
- Effect of abciximab on late adverse events in patients with diabetes mellitus undergoing stent implantation.
- Systematic review: transient left ventricular apical ballooning: a Syndrome that mimics ST-segment elevation myocardial infarction.
- Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning Syndrome.
- Comparative outcomes of percutaneous Coronary interventions in diabetics vs non-diabetics with prior Coronary artery bypass grafting.
- Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous Coronary intervention in unselected patients: results from the EVENT (evaluat...
- Effect of enhanced external counterpulsation on circulating CD34+ progenitor cell subsets.
- Segmental Coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques.
- Effects of aliskiren, a renin inhibitor, on biomarkers of platelet activity, coagulation and fibrinolysis in subjects with multiple risk factors for vascular Disease.
- Smartphone ECG for evaluation of STEMI: Results of the ST LEUIS Pilot Study.
Schools
University Of Minnesota Medical School
Duke University Med Center
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Duke University Hospital -
University of Minnesota Medical School
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1194790790 | |
| NPPES Provider LastName | BARSNESS | |
| NPPES Provider FirstName | GREGORY | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Cardiology | |
| Total Claim Count | 50.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1194790790 |
| Last Name Of The Provider | BARSNESS |
| First Name Of The Provider | GREGORY |
| View All |
Similar Doctors
|
|
Dr. Paul A. Friedman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Verghese Mathew, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pankaj Madan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abhiram Prasad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger L. Click, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph T. Breen, MD |
|
|
Dr. Kalkidan G. Bishu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin T. Cragun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theophilus E. Owan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Driscoll, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul W. Wennberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nandan S. Anavekar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. R Scott Wright, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Waldemar E. Wysokinski, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. John R. Hoyt, MD |
|
|
Lauren R. Trapp, PA |